The efficacy of penile duplex ultrasound in erectile dysfunction management decision-making

Erectile dysfunction (ED) poses a significant challenge in clinical practice, necessitating accurate diagnostic strategies to distinguish between organic and psychogenic causes. Current guidelines advocate a comprehensive approach involving medical history, physical examination and blood tests, with...

Descripción completa

Detalles Bibliográficos
Autores: Cocci, Andrea, Pezzoli, Marta, Re, Mattia Lo, Ralph, David, Christopher, Nim, Osmonov, Daniar, Bettocchi, Carlo, Djinovic, Rados, Antonini, Gabriele, Levine, Laurence, Martínez Salamanca, Juan Ignacio, Romero Otero, Javier, Egydio, Paulo, Moncada Iribarren, Ignacio, Hatzichristodoulou, Georgios|||0000-0002-3170-7362, Perito, Paul, Antoine, Faix, Park, Hyun Jun|||0000-0003-0566-9574, Rolle, Luigi, Kadıoğlu, Ateş, Ruiz-Castañé, Eduardo|||0000-0002-7469-4610, Renterghem, Koenraad Van, Valenzuela, Robert J., Wilson, Steven K., Tomada, Nuno, Capece, Marco, Falcone, Marco|||0000-0003-1101-892X
Tipo de recurso: artículo
Fecha de publicación:2024
País:España
Institución:Universitat Autònoma de Barcelona
Repositorio:Dipòsit Digital de Documents de la UAB
Idioma:inglés
OAI Identifier:oai:ddd.uab.cat:306958
Acceso en línea:https://ddd.uab.cat/record/306958
https://dx.doi.org/urn:doi:10.22514/jomh.2024.084
Access Level:acceso abierto
Palabra clave:Erectile dysfunction
Penile duplex ultrasound
Intracavernous injection
Descripción
Sumario:Erectile dysfunction (ED) poses a significant challenge in clinical practice, necessitating accurate diagnostic strategies to distinguish between organic and psychogenic causes. Current guidelines advocate a comprehensive approach involving medical history, physical examination and blood tests, with second-level analyses like the intracavernous injection of vasoactive drugs (ICI test) and penile duplex ultrasound (PDU) reserved for specific cases. A survey involving 24 urologists experienced in ED was conducted to assess their opinions on the appropriateness of the ICI test and PDU in six clinical scenarios. Results were analyzed using pie charts, revealing varied preferences among experts. The responses indicated diverse viewpoints, with preferences for the ICI test or PDU depending on the patient's age, comorbidities, response to phosphodiesterase type 5 inhibitors (PDE5i) and concomitant Peyronie's disease. In some cases, a significant proportion of experts opted for neither test. The study highlights the lack of consensus among experts regarding the routine use of PDU in ED management. Despite its diagnostic capabilities, the clinical utility of PDU remains unclear, and its role may be more justified in certain populations with anatomical abnormalities or specific conditions. The need for rigorous research to determine the impact of PDU on ED management decision-making is emphasized.

Similares en LA Referencia